Hookipa Biotech's Series A Round

Hookipa Biotech raised a round of funding on October 17, 2011.

Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious diseases and cancer using novel proprietary arenavirus vector platforms.…

Articles about Hookipa Biotech's Series A Round: